Crossmark

In Vitro and In Silico Evaluation of 2-(1H-Benzo[d]imidazol-2-yl)-3-(4-(piperazin-1-yl)phenyl)propanenitrile as Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Crossref DOI link: https://doi.org/10.1134/S1068162024040174

Published Online: 2024-08-05

Published Print: 2024-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sarita, K.

Kumar, N.

Agrawal, A.

Mali, S. N.

Sharma, S.
License Information

Text and Data Mining valid from 2024-08-01

Version of Record valid from 2024-08-01
More Information

Article History

Received: 8 January 2024

Revised: 19 January 2024

Accepted: 20 January 2024

First Online: 5 August 2024

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

: This article does not contain any studies involving patients or animals as test objects.

: Informed consent was not required for this article. No conflicts of interest was declared by the authors.

Document is current

Any future updates will be listed below